cocaine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (15.15) | 18.7374 |
1990's | 12 (36.36) | 18.2507 |
2000's | 14 (42.42) | 29.6817 |
2010's | 2 (6.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, P; Boja, JW; Carroll, FI; Cline, EJ; Kuhar, MJ; Lewin, AH; Mitchell, WM; Scheffel, U | 1 |
Brownell, AL; Brownell, GL; Elmaleh, D; Hantraye, P; Isacson, O; Madras, BK; Spealman, RD; Wüllner, U | 1 |
Heikkila, RE; Nicklas, WJ; Ofori, S | 1 |
Debler, EA; Hashim, A; Lajtha, A; Sershen, H | 1 |
Heikkila, RE; Kindt, MV; Mayer, RA | 1 |
Jarvis, MF; Mayer, RA; Wagner, GC | 1 |
Hashim, A; Lajtha, A; Reith, ME; Sershen, H | 1 |
al-Tikriti, MS; Elsworth, JD; Innis, RB; Redmond, DE; Roth, RH; Sladek, JR; Taylor, JR | 1 |
Brownell, AL; Brownell, GL; Burns, L; Elmaleh, D; Hantraye, P; Pakzaban, P; Petto, AJ; Shoup, T; Spealman, RD; Wüllner, U | 1 |
Giovanni, A; Heikkila, RE; Sieber, BA; Sonsalla, PK | 1 |
Giovanni, A; Heikkila, RE; Sonsalla, PK | 1 |
Isacson, O | 1 |
Cardoso, F; Jankovic, J | 1 |
Brownell, AL; Brownell, GL; Elmaleh, DR; Fischman, AJ; Madras, BK; Meltzer, PC; Shoup, TM | 1 |
Babich, JW; Barrow, SA; Elmaleh, DR; Fischman, AJ; Hanson, RN; Madras, BK; Meltzer, P | 1 |
Brownell, AL; Isacson, O; Jenkins, BG | 1 |
Donovan, DM; Kirstein, CL; Kostic, V; Miner, LL; Perry, MP; Philpot, RM; Przedborski, S; Revay, RS; Rothman, RB; Schindler, CW; Sharpe, LG; Uhl, GR | 1 |
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Goulet, M; Grondin, R; Lavertu, N; Lemieux, AM; Morissette, M | 1 |
D'Souza, UM; Eisch, AJ; Hwang, CK; Kim, YM; Lammers, CH; Lee, SH; Mouradian, MM; Nestler, EJ; Yajima, S; Yang, Y | 1 |
Kulak, JM; McIntosh, JM; Polonskaya, Y; Quik, M | 1 |
Chen, JC; Hwang, JJ; Liao, MH; Lin, KJ; Pan, WH; Ting, G; Wey, SP; Yen, TC | 1 |
Kulak, JM; McIntosh, JM; Musachio, JL; Quik, M | 1 |
Hanger, D; Joyce, JN; Reploge, M; Yarkov, AV | 1 |
Belin, D; Bezard, E; Dovero, S; Duconger, S; Gross, CE; Jaber, M; Jackson-Lewis, V; Piazza, PV; Przedborski, S | 1 |
Brownell, AL; Chen, YC; Isacson, O; Jenkins, BG; Sanchez-Pernaute, R | 1 |
Andringa, G; Bol, JG; Booij, J; de Bruin, K; Drukarch, B; Habraken, JB; Sorman, K | 1 |
Faherty, CJ; Lloyd, SA; Smeyne, RJ | 1 |
Burton, NC; Guilarte, TR; Kensler, TW | 1 |
McIntosh, JM; O'Leary, K; Parameswaran, N; Quik, M | 1 |
Bordia, T; Huang, LZ; Michael McIntosh, J; Parameswaran, N; Quik, M | 1 |
Gai, Y; Guo, LH; Jiang, ZH; Qin, GW; Zhao, G; Zheng, XW | 1 |
Hayashi, T; Saiki, H; Takahashi, J; Takahashi, R | 1 |
Brown, CA; Karimi, M; Loftin, SK; Perlmutter, JS; Tian, L | 1 |
1 review(s) available for cocaine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Movement disorders.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcoholism; Amphetamines; Cocaine; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
32 other study(ies) available for cocaine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
In vivo binding of [125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Organ Specificity | 1992 |
Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Disease Models, Animal; Dopamine; Immunohistochemistry; Macaca fascicularis; Motor Activity; Nerve Fibers; Parkinson Disease, Secondary; Radioligand Assay; Tomography, Emission-Computed | 1992 |
Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Corpus Striatum; Dopamine; In Vitro Techniques; Lactates; Lactic Acid; Male; Mice; NAD; Neurotransmitter Uptake Inhibitors; Rats; Tyrosine 3-Monooxygenase | 1989 |
Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Biological Transport; Cocaine; Corpus Striatum; Dopamine; Kinetics; Mazindol; Mice; Nicotine; Piperazines; Pyridines; Synaptosomes | 1988 |
Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Flunarizine; Male; Mice; Nalidixic Acid; Naphthyridines; Piperazines; Pyridines; Pyridinium Compounds; Pyrroles; Rats; Rats, Inbred Strains; Substantia Nigra | 1986 |
Cocaine blocks the dopamine depletion induced by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Corpus Striatum; Dopamine; Male; Mice; Pyridines; Receptors, Dopamine | 1985 |
Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Corpus Striatum; Depression, Chemical; Dopamine; Hydroxydopamines; In Vitro Techniques; Kinetics; Mice; Mice, Inbred BALB C; Pyridines; Spiperone; Synaptosomes | 1984 |
Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Chlorocebus aethiops; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Fetal Tissue Transplantation; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra; Transplantation, Heterotopic; Transplantation, Homologous | 1994 |
Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Dopamine; Motor Activity; Nerve Endings; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed | 1994 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Guanethidine; Male; Mice; Microdialysis; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neurons; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptosomes | 1994 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dose-Response Relationship, Drug; Guanethidine; Male; Mice; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity | 1994 |
Clinical and preclinical PET correlates of parkinsonism with 11C-WIN 35,428.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbon Radioisotopes; Cocaine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1994 |
Cocaine congeners as PET imaging probes for dopamine terminals.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carbon Radioisotopes; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Macaca fascicularis; Male; Nerve Endings; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1996 |
SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Carrier Proteins; Cocaine; Contrast Media; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Macaca mulatta; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Parkinson Disease; Parkinson Disease, Secondary; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Biomarkers; Cocaine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Haplorhini; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Models, Biological; Parkinson Disease; Tomography, Emission-Computed; Visual Cortex | 1999 |
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Genetic Variation; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred Strains; Mice, Transgenic; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Reward; Serotonin; Substantia Nigra; Transgenes; Tyrosine 3-Monooxygenase | 1999 |
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Benzoates; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Female; Macaca fascicularis; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Organophosphorus Compounds; Parkinsonian Disorders; Protein Subunits; Radioligand Assay; Receptors, GABA-B; RNA, Messenger; Substantia Nigra; Subthalamic Nucleus | 2001 |
Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Sequence; Animals; Autoradiography; Brain; Cell Line; Cocaine; Conserved Sequence; Corpus Striatum; Dopamine; Dopamine Antagonists; Down-Regulation; Gene Expression Regulation; Haloperidol; In Situ Hybridization; Kruppel-Like Transcription Factors; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neuroblastoma; Neurons; Receptors, Dopamine; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Transcription Factors; Transfection; Tumor Cells, Cultured; Zinc Fingers | 2001 |
Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cocaine; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Habenula; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Neural Pathways; Neurons; Parkinson Disease, Secondary; Putamen; Pyridines; Receptors, Nicotinic; Saimiri; Substantia Nigra | 2001 |
Biodistribution study of [99mTc] TRODAT-1 alone or combined with other dopaminergic drugs in mice with macroautoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Cocaine; Dopamine Agents; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred ICR; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tropanes | 2002 |
Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Azetidines; Brain Chemistry; Caudate Nucleus; Cocaine; Conotoxins; Neostriatum; Parkinson Disease, Secondary; Putamen; Radioligand Assay; Receptors, Nicotinic; Saimiri; Substantia Nigra | 2002 |
Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Benzopyrans; Carbidopa; Cocaine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Female; Grooming; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Oxazines; Pyrroles; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereotyped Behavior | 2003 |
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biomarkers; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Drug Resistance; Environment; Exploratory Behavior; Growth Substances; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Neurotoxins; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos | 2003 |
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Brain; Brain Mapping; Cerebrovascular Circulation; Cocaine; Dopamine; Dopamine Agents; Macaca fascicularis; Magnetic Resonance Imaging; Motor Activity; Parkinsonian Disorders; Positron-Emission Tomography; Radioligand Assay | 2004 |
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2005 |
Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Cocaine; DNA Primers; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Immunohistochemistry; Mice; Parkinson Disease, Secondary; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
In vivo modulation of the Parkinsonian phenotype by Nrf2.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antineoplastic Agents; Autoradiography; Cocaine; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Iodine Isotopes; Male; Mice; Mice, Inbred ICR; Mice, Knockout; NF-E2-Related Factor 2; Parkinsonian Disorders; Phenotype; Thiones; Thiophenes | 2006 |
Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azetidines; Brain; Cocaine; Conotoxins; Cotinine; Dopamine; Dopamine Agents; Female; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Saimiri | 2008 |
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Analysis of Variance; Animals; Autoradiography; Cocaine; Conotoxins; Corpus Striatum; Cotinine; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Iodine Isotopes; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Saimiri; Substantia Nigra; Time Factors | 2009 |
In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cocaine; Cricetinae; Cricetulus; Dopamine; Dopamine Agents; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Norepinephrine; Parkinson Disease; Phenols; Psoralea; Rats; Rats, Sprague-Dawley; Synaptosomes; Tyrosine 3-Monooxygenase | 2009 |
Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Mapping; Carbon Radioisotopes; Cocaine; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Macaca fascicularis; Parkinsonian Disorders; Positron-Emission Tomography; Severity of Illness Index; Video Recording | 2010 |
In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Functional Laterality; Macaca; Male; Neurons; Parkinsonian Disorders; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2014 |